comparemela.com
  1. Home
  2. Live Updates
  3. Phanes Therapeutics - Breaking News

Latest Breaking News On - Phanes therapeutics - Page 8 : comparemela.com

PHANES THERAPEUTICS TO PRESENT AT BIOFUTURE™ 2022

/PRNewswire/ Phanes Therapeutics, Inc., a clinical stage biotech company focused on innovative drug discovery and development in oncology, today announced.

New yorkUnited statesMing wangLotte palace hotelPrnewswire phanes therapeutics incPhanes therapeutics incLotte new york palaceSara demyPhanes therapeuticsNew york city

PHANES THERAPEUTICS TO PRESENT AT BIOFUTURE™ 2022

Company s CEO to present its innovative oncology pipeline and proprietary bispecific antibody technology platformsSAN DIEGO, Nov. 4, 2022 /PRNewsw.

New yorkUnited statesMing wangLotte palace hotelPrnewswire phanes therapeutics incPhanes therapeutics incLotte new york palaceSara demyPhanes therapeuticsNew york city

Phanes Therapeutics announces FDA IND clearance for PT217, an anti-DLL3/anti-CD47 bispecific antibody being developed for patients with small cell lung cancer and other neuroendocrine cancers

/PRNewswire/ Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on oncology, announced today that it has received clearance from.

United statesMing wangUniversity of texas md anderson cancer centerPrnewswire phanes therapeutics incDrug administrationPhanes therapeutics incCancer centerPhanes therapeutics

Phanes Therapeutics Announces First Patient Dosed in Phase 1 Study of PT199 for Advanced Solid Tumors

/PRNewswire/ Phanes Therapeutics, Inc. (Phanes), an emerging leader in innovative discovery research and clinical development in oncology, announced today.

United statesSan diegoMing wangPrnewswire phanes therapeutics incPhanes therapeutics incPhanes therapeutics

Phanes Therapeutics anti-CD47 antibody patent granted in the US

/PRNewswire/ Phanes Therapeutics, Inc. (Phanes), an emerging leader in innovative discovery research and clinical development in oncology, announced today.

United statesSan diegoMing wangTrademark officePrnewswire phanes therapeutics incPhanes therapeutics incPhanes therapeutics

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.